DNA Chip Research, Inc. engages in the business of contract analysis and Deoxyribonucleic Acid (DNA) chip technology development services. It operates through the following segments: Contract Research and Product Sales. The Contract Research segment offers contract analytical services, genomic medicine analysis, diagnostic support, and research and development services. The Product Sales segment engages in the manufacture and sale of DNA chip, life science and biotechnology information equipment. The company was founded by Kenichi Matsubara on April 1, 1999 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company